Advanced Search

CN 34-1304/RISSN 1674-3679

Volume 27 Issue 1
Jan.  2023
Turn off MathJax
Article Contents
YANG Pei, ZHANG Yu-jie, ZHONG Wen-fang, WANG Xiao-meng, LYU Yue-bin, MAO Chen. Associations of single nucleotide polymorphisms of HDAC9 and PPP3CA genes with frailty in the Chinese elderly people[J]. CHINESE JOURNAL OF DISEASE CONTROL & PREVENTION, 2023, 27(1): 77-81. doi: 10.16462/j.cnki.zhjbkz.2023.01.014
Citation: YANG Pei, ZHANG Yu-jie, ZHONG Wen-fang, WANG Xiao-meng, LYU Yue-bin, MAO Chen. Associations of single nucleotide polymorphisms of HDAC9 and PPP3CA genes with frailty in the Chinese elderly people[J]. CHINESE JOURNAL OF DISEASE CONTROL & PREVENTION, 2023, 27(1): 77-81. doi: 10.16462/j.cnki.zhjbkz.2023.01.014

Associations of single nucleotide polymorphisms of HDAC9 and PPP3CA genes with frailty in the Chinese elderly people

doi: 10.16462/j.cnki.zhjbkz.2023.01.014
YANG Pei and ZHANG Yu-jie contributed equally to the work
Funds:

National Natural Science Foundation of China 82173588

National Natural Science Foundation of China 81973109

National Natural Science Foundation of China 82001476

More Information
  • Corresponding author: MAO Chen, E-mail: maochen9@smu.edu.cn
  • Received Date: 2022-03-24
  • Rev Recd Date: 2022-06-19
  • Available Online: 2023-02-09
  • Publish Date: 2023-01-10
  •   Objective  To explore the associations between the single nucleotide polymorphism (SNP) of histone deacetylase 9 (HDAC9) and calcineurin catalytic subunit A (PPP3CA) and frailty in the Chinese elderly people.  Methods  Our study included 665 participants in the frailty group and 3 388 participants in the control group. Associations between rs2074633 and rs17030795 gene polymorphisms and frailty were evaluated based on genotype frequencies, and five genetic models (co-dominance, additive, dominance, recessive and over-dominance models).  Results  In co-dominance model, individuals carrying HDAC9 rs2074633 TC genotype (OR=1.99, 95% CI: 1.36-2.90) and CC genotype (OR=2.15, 95% CI: 1.48-3.13) were more likely to develop frailty, compared with those carrying TT genotype3. The rs2074633 polymorphisms increased the risk of frailty in both additive model (OR=1.28, 95% CI: 1.11-1.47), dominant model (OR=2.07, 95% CI: 1.44-2.98) and recessive model (OR=1.21, 95% CI: 1.01-1.45). In co-dominance model, individuals carrying PPP3CA rs17030795 AG (OR=1.72, 95% CI: 1.19-2.51) genotype and GG (OR=1.98, 95% CI: 1.37-2.87) genotype were more likely to develop frailty, compared with those carrying AA genotype. The rs17030795 polymorphisms increased the risk of frailty in both additive model (OR=1.28, 95% CI: 1.11-1.48), dominant model (OR=1.85, 95% CI: 1.29-2.66) and recessive model (OR=1.25, 95% CI: 1.04-1.50).   Conclusions  The rs2074633and rs17030795 polymorphisms are associated with the increased risk of frailty.
  • loading
  • [1]
    Fried LP, Tangen CM, Walston J, et al. Frailty in older adults: evidence for a phenotype[J]. J Gerontol A Biol Sci Med Sci, 2001, 56(3): M146-M156. DOI: 10.1093/gerona/56.3.M146.
    [2]
    Clegg A, Young J, Iliffe S, et al. Frailty in elderly people[J]. Lancet, 2013, 381(9868): 752-762. DOI: 10.1016/S0140-6736(12)62167-9.
    [3]
    Hoogendijk EO, Afilalo J, Ensrud KE, et al. Frailty: implications for clinical practice and public health[J]. Lancet, 2019, 394(10206): 1365-1375. DOI: 10.1016/S0140-6736(19)31786-6.
    [4]
    Sathyan S, Verghese J. Genetics of frailty: a longevity perspective[J]. Transl Res, 2020, 221: 83-96. DOI: 10.1016/j.trsl.2020.03.005.
    [5]
    Inglés M, Mas-Bargues C, Gimeno-Mallench L, et al. Relation between genetic factors and frailty in older adults[J]. J Am Med Dir Assoc, 2019, 20(11): 1451-1457. DOI: 10.1016/j.jamda.2019.03.011.
    [6]
    Cruz-Jentoft AJ, Bahat G, Bauer J, et al. Sarcopenia: revised European consensus on definition and diagnosis[J]. Age Ageing, 2019, 48(4): 601. DOI: 10.1093/ageing/afyz046.
    [7]
    Bycroft C, Freeman C, Petkova D, et al. The UK Biobank resource with deep phenotyping and genomic data[J]. Nature, 2018, 562(7726): 203-209. DOI: 10.1038/s41586-018-0579-z.
    [8]
    Zhang CL, McKinsey TA, Olson EN. Association of class Ⅱ histone deacetylases with heterochromatin protein 1: potential role for histone methylation in control of muscle differentiation[J]. Mol Cell Biol, 2002, 22(20): 7302-7312. DOI: 10.1128/MCB.22.20.7302-7312.2002.
    [9]
    Tang H, Goldman D. Activity-dependent gene regulation in skeletal muscle is mediated by a histone deacetylase (HDAC)-dach2-myogenin signal transduction cascade[J]. Proc Natl Acad Sci USA, 2006, 103(45): 16977-16982. DOI: 10.1073/pnas.0601565103.Epub2006Oct30.
    [10]
    Chen HH, Tsai LK, Liao KY, et al. Muscle-restricted nuclear receptor interaction protein knockout causes motor neuron degeneration through down-regulation of myogenin at the neuromuscular junction[J]. J Cachexia Sarcopenia Muscle, 2018, 9(4): 771-785. DOI: 10.1002/jcsm.12299.
    [11]
    Cardoso AL, Fernandes A, Aguilar-Pimentel JA, et al. Towards frailty biomarkers: candidates from genes and pathways regulated in aging and age-related diseases[J]. Ageing Res Rev, 2018, 47: 214-277. DOI: 10.1016/j.arr.2018.07.004.
    [12]
    Bennett S, Song X, Mitnitski A, et al. A limit to frailty in very old, community-dwelling people: a secondary analysis of the Chinese longitudinal health and longevity study[J]. Age Ageing, 2013, 42(3): 372-377. DOI: 10.1093/ageing/afs180.
    [13]
    Gu D, Dupre ME, Sautter J, et al. Frailty and mortality among Chinese at advanced ages[J]. J Gerontol B Psychol Sci Soc Sci, 2009, 64(2): 279-289. DOI: 10.1093/geronb/gbn009.
    [14]
    Rockwood K, Andrew M, Mitnitski A. A comparison of two approaches to measuring frailty in elderly people[J]. J Gerontol a Biol Sci Med Sci, 2007, 62(7): 738-743. DOI: 10.1093/gerona/62.7.738.
    [15]
    Zeng Y, Nie C, Min J, et al. Novel loci and pathways significantly associated with longevity[J]. Sci Rep, 2016, 6: 21243. DOI: 10.1038/srep21243.
    [16]
    Li L, Xiong WC, Mei L. Neuromuscular junction formation, aging, and disorders[J]. Annu Rev Pysiol, 2018, 80: 159-188. DOI: 10.1146/annurev-physiol-022516-034255.
    [17]
    Zhou X, Marks PA, Rifkind RA, et al. Cloning and characterization of a histone deacetylase, HDAC9[J]. Proc Natl Acad Sci USA, 2001, 98(19): 10572-10577. DOI: 10.1073/pnas.191375098.
    [18]
    Wang M, Gu M, Li Z, et al. HDAC9 polymorphisms predict susceptibility, severity, and short-term outcome of large artery atherosclerotic stroke in Chinese ppulation[J]. J Mol Neurosci, 2019, 67(1): 165-171. DOI: 10.1007/s12031-018-1221-0.
    [19]
    Haberland M, Arnold MA, McAnally J, et al. Regulation of HDAC9 gene expression by MEF2 establishes a negative-feedback loop in the transcriptional circuitry of muscle differentiation[J]. Mol Cell Biol, 2007, 27(2): 518-525. DOI: 10.1128/MCB.01415-06.
    [20]
    Macpherson PCD, Farshi P, Goldman D. Dach2-HDAC9 signaling regulates reinnervation of muscle endplates[J]. Development, 2015, 142(23): 4038-4048. DOI: 10.1242/dev.125674.
    [21]
    Roy J, Cyert MS. Identifying new substrates and functions for an old enzyme: calcineurin[J]. Cold Spring Harb Perspect Biol, 2020, 12(3): a035436. DOI: 10.1101/cshperspect.a035436.
    [22]
    Li H, Rao A, Hogan PG. Interaction of calcineurin with substrates and targeting proteins[J]. Trends Cell Biol, 2011, 21(2): 91-103.1016/j.tcb.2010.09.011. doi: 1016/j.tcb.2010.09.011
    [23]
    Myers CT, Stong N, Mountier EI, et al. De novo mutations in PPP3CA cause severe neurodevelopmental disease with seizures[J]. Am J Hum Genet, 2017, 101(4): 516-524. DOI: 10.1016/j.ajhg.2017.08.013.
    [24]
    Rydzanicz M, Wachowska M, Cook EC, et al. Novel calcineurin a (PPP3CA) variant associated with epilepsy, constitutive enzyme activation and downregulation of protein expression[J]. Eur J Hum Genet, 2019, 27(1): 61-69. DOI: 10.1038/s41431-018-0254-8.
    [25]
    薛梦婷, 姜荣荣, 徐桂华, 等. 老年人衰弱的研究进展[J]. 中国老年学杂志, 2021, 41(8): 1761-1765. DOI: 10.3969/j.issn.1005-9202.2021.08.056.

    Xue MT, Jiang RR, Xu GH, et al. Research progress of frailty in the elderly[J]. Chin J Geriatr, 2021, 41(8): 1761-1765. DOI: 10.3969/j.issn.1005-9202.2021.08.056.
    [26]
    周立远, 吴天清, 张旭东, 等. 不同年龄大鼠心血管组织中钙调神经磷酸酶活性的变化[J]. 中国医药指南, 2012, 10(17): 95-97. DOI: 10.3969/j.issn.1671-8194.2012.17.061.

    Zhou LY, Wu TQ, Zhang XD, et al. Changes of calcineurin activity in cardiovascular tissues of rats of different ages[J]. Guide of China Medicine, 2012, 10(17): 95-97. DOI: 10.3969/j.issn.1671-8194.2012.17.061.
  • 加载中

Catalog

    通讯作者: 陈斌, bchen63@163.com
    • 1. 

      沈阳化工大学材料科学与工程学院 沈阳 110142

    1. 本站搜索
    2. 百度学术搜索
    3. 万方数据库搜索
    4. CNKI搜索

    Tables(4)

    Article Metrics

    Article views (324) PDF downloads(49) Cited by()
    Proportional views
    Related

    /

    DownLoad:  Full-Size Img  PowerPoint
    Return
    Return